Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
DOI:
https://doi.org/10.2340/actadv.v102.2151Keywords:
prurigo nodularis, dupilumab, depression, filaggrinAbstract
Abstract is missing (Short communication)
Downloads
References
Zeidler C, Yosipovitch G, Ständer S. Prurigo nodularis and its management. Dermatol Clin 2018; 36: 189-197.
https://doi.org/10.1016/j.det.2018.02.003 DOI: https://doi.org/10.1016/j.det.2018.02.003
Williams KA, Roh YS, Brown I, Sutaria N, Bakhshi P, Choi J, et al. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis. Expert Rev Clin Pharmacol 2021; 14: 67-77.
https://doi.org/10.1080/17512433.2021.1852080 DOI: https://doi.org/10.1080/17512433.2021.1852080
Fukushi S, Yamasaki K, Aiba S. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol 2011; 165: 990-996.
https://doi.org/10.1111/j.1365-2133.2011.10498.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10498.x
Toffoli L, Farinazzo E, Zelin E, Agozzino M, Dianzani C, Di Meo N, et al. Dupilumab as promising treatment for prurigo nodularis: current evidences. J Dermatolog Treat 2021; 15: 1-6.
https://doi.org/10.1080/09546634.2021.1886232 DOI: https://doi.org/10.1080/09546634.2021.1886232
Calugareanu A, Jachiet M, Tauber M, Nosbaum A, Aubin F, Misery L, et al. Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients. J Eur Acad Dermatol Venereol 2020; 34: 74-76.
https://doi.org/10.1111/jdv.15957 DOI: https://doi.org/10.1111/jdv.15957
Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-654.
https://doi.org/10.1038/ng2020 DOI: https://doi.org/10.1038/ng2020
Janmohamed SR, Gwillim EC, Yousaf M, Patel KR, Silverberg JI. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis. Arch Dermatol Res 2021; 313: 669-677.
https://doi.org/10.1007/s00403-020-02148-0 DOI: https://doi.org/10.1007/s00403-020-02148-0
Jørgensen KM, Egeberg A, Gislason GH, Skov L, Thyssen JP. Anxiety, depression and suicide in patients with prurigo nodularis. J Eur Acad Dermatol Venereol 2017; 31: 106-107.
https://doi.org/10.1111/jdv.13827 DOI: https://doi.org/10.1111/jdv.13827
Fölster-Holst R, Reimer R, Neumann C, Proksch E, Rodriguez E, Weidinger S, et al. Comparison of epidermal barrier integrity in adults with classic atopic dermatitis, atopic prurigo and non-atopic prurigo nodularis. Biology (Basel) 2021; 10: 1008.
https://doi.org/10.3390/biology10101008 DOI: https://doi.org/10.3390/biology10101008
Published
How to Cite
License
Copyright (c) 2022 Louise Lönndahl, Maria Lundqvist, Maria Bradley, Emma K. Johansson
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
